mibefradil has been researched along with Reperfusion Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gezici, A; Ozturk, H | 1 |
Duran, H; Ozturk, H; Uzunlar, AK | 1 |
2 other study(ies) available for mibefradil and Reperfusion Injury
Article | Year |
---|---|
The effects of mibefradil, a T-type Ca2+ channels blocker, on the renal dysfunction and injury caused by ischemia-reperfusion of the rat kidney.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Blood Urea Nitrogen; Calcium Channel Blockers; Creatinine; Disease Models, Animal; Immunohistochemistry; Kidney; Kidney Diseases; Kidney Function Tests; Male; Mibefradil; Nephrectomy; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Reperfusion Injury; Risk Factors; Sensitivity and Specificity | 2005 |
Mibefradil, a T-type Ca2+ channel blocker, protects against mesenteric ischemia-reperfusion-induced oxidative injury and histologic alterations in intestinal mucosa in rats.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Glutathione Peroxidase; Intestinal Mucosa; Lipid Peroxidation; Mesentery; Mibefradil; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Severity of Illness Index; Superoxide Dismutase; Treatment Outcome | 2006 |